Home › NDC Lookup › Labelers › Takeda Pharmaceuticals America, Inc.

Takeda Pharmaceuticals America, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 42227 (Takeda Pharmaceuticals America, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

2
Package NDCs
2
Products
2
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
2
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
HUMAN C1-ESTERASE INHIBITOR 2
By dosage form
INJECTION, POWDER, LYOPHILIZED, FO... 1
KIT 1

Browse records — 2 products

Drug / product Billing NDC NADAC / unit Status
Cinryze HUMAN C1-ESTERASE INHIBITOR 500 [iU]/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Takeda · NDC 42227-0081-05 · 1 VIAL, SINGLE-USE in 1 CARTON (42227-081-05) / 5 mL in 1 VIAL, SINGLE-USE (42227-081-01) 42227-0081-05 — On market View →
Cinryze HUMAN C1-ESTERASE INHIBITOR KIT Takeda · NDC 42227-0083-01 · J0598 · 1 KIT in 1 CARTON (42227-083-01) * 5 mL in 1 VIAL, SINGLE-USE (42227-081-01) * 5 mL in 1 VIAL, GLASS (64764-515-50) 42227-0083-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.